Pharmaceuticals Valuation: Drugs, Patents & Trials ??
Key Drivers
Pipeline probability of success
Patent life and exclusivity
Reimbursement environment
Approaches
rNPV (risk-adjusted NPV) for R&D
Comparable biotech multiples
Scenario modelling for launch uptake
Way Forward:
Diversify portfolio, prepare for generics
Build strong payer narratives
Startup ka Rs. 200 Crore Valuation — Real ya Hawa? | Practical Equity Valuation | AIF Ep 7
Read More..
3 Valuation Methods Every AIF Professional Must Master | Market, Income & Cost Approach #valueedge
Read More..
SEBI's 2023 AIF Circular Changed EVERYTHING — What Fund Managers Must Know Now | Ep 5
Read More..Absolutely. We have IBBI-Registered Valuers under all three categories—Land & Building, Plant & Machinery, and Securities/Financial Assets. Our team also includes experienced chartered accountants and engineers.
Yes. We offer remote/desk-based valuation for startups, financial assets, and select use-cases. For physical assets, we usually require on-site verification.
Yes. Client confidentiality is paramount. All data shared is stored securely and not disclosed to any third party without your consent.